Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study

Robert C. Kaplan, Aileen P. McGinn, Alison E. Baird, Susan L. Hendrix, Charles Kooperberg, John Lynch, Daniel M. Rosenbaum, Karen Johnson, Howard D. Strickler, Sylvia Wassertheil-Smoller

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Inflammatory and hemostasis-related biomarkers may identify women at risk of stroke. Methods: Hormones and Biomarkers Predicting Stroke is a study of ischemic stroke among postmenopausal women participating in the Women's Health Initiative observational study (n = 972 case-control pairs). A Biomarker Risk Score (BRS) was derived from levels of 7 inflammatory and hemostasis-related biomarkers that appeared individually to predict risk of ischemic stroke: C-reactive protein (CRP), interleukin-6, tissue plasminogen activator, D-dimer, white blood cell count, neopterin, and homocysteine. The c index was used to evaluate discrimination. Results: Of all the individual biomarkers examined, CRP emerged as the only independent single predictor of ischemic stroke (adjusted odds ratio comparing Quartile4 v Quartile1 = 1.64, 95% confidence interval: 1.15-2.32, P = .01) after adjustment for other biomarkers and standard stroke risk factors. The BRS identified a gradient of increasing stroke risk with a greater number of elevated inflammatory/hemostasis biomarkers, and improved the c index significantly compared with standard stroke risk factors (P = .02). Among the subset of individuals who met current criteria for high-risk levels of CRP (>3.0 mg/L), the BRS defined an approximately 2-fold gradient of risk. We found no evidence for a relationship between stroke and levels of E-selectin, fibrinogen, tumor necrosis factor-α, vascular cell adhesion molecule-1, prothrombin fragment 1+2, Factor VIIC, or plasminogen activator inhibitor-1 antigen (P > .15). Discussion: The findings support the further exploration of multiple biomarker panels to develop approaches for stratifying an individual's risk of stroke.

Original languageEnglish (US)
Pages (from-to)344-355
Number of pages12
JournalJournal of Stroke and Cerebrovascular Diseases
Volume17
Issue number6
DOIs
StatePublished - Nov 1 2008

Fingerprint

Women's Health
Hemostasis
Observational Studies
Biomarkers
Stroke
Inflammation
C-Reactive Protein
Neopterin
E-Selectin
Vascular Cell Adhesion Molecule-1
Plasminogen Activator Inhibitor 1
Homocysteine
Tissue Plasminogen Activator
Leukocyte Count
Fibrinogen
Interleukin-6
Tumor Necrosis Factor-alpha
Odds Ratio
Hormones
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women : The Women's Health Initiative Observational Study. / Kaplan, Robert C.; McGinn, Aileen P.; Baird, Alison E.; Hendrix, Susan L.; Kooperberg, Charles; Lynch, John; Rosenbaum, Daniel M.; Johnson, Karen; Strickler, Howard D.; Wassertheil-Smoller, Sylvia.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 17, No. 6, 01.11.2008, p. 344-355.

Research output: Contribution to journalArticle

Kaplan, RC, McGinn, AP, Baird, AE, Hendrix, SL, Kooperberg, C, Lynch, J, Rosenbaum, DM, Johnson, K, Strickler, HD & Wassertheil-Smoller, S 2008, 'Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study', Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 6, pp. 344-355. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.04.006
Kaplan, Robert C. ; McGinn, Aileen P. ; Baird, Alison E. ; Hendrix, Susan L. ; Kooperberg, Charles ; Lynch, John ; Rosenbaum, Daniel M. ; Johnson, Karen ; Strickler, Howard D. ; Wassertheil-Smoller, Sylvia. / Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women : The Women's Health Initiative Observational Study. In: Journal of Stroke and Cerebrovascular Diseases. 2008 ; Vol. 17, No. 6. pp. 344-355.
@article{13fb687f82a64231bfaab76df43f95f8,
title = "Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study",
abstract = "Background: Inflammatory and hemostasis-related biomarkers may identify women at risk of stroke. Methods: Hormones and Biomarkers Predicting Stroke is a study of ischemic stroke among postmenopausal women participating in the Women's Health Initiative observational study (n = 972 case-control pairs). A Biomarker Risk Score (BRS) was derived from levels of 7 inflammatory and hemostasis-related biomarkers that appeared individually to predict risk of ischemic stroke: C-reactive protein (CRP), interleukin-6, tissue plasminogen activator, D-dimer, white blood cell count, neopterin, and homocysteine. The c index was used to evaluate discrimination. Results: Of all the individual biomarkers examined, CRP emerged as the only independent single predictor of ischemic stroke (adjusted odds ratio comparing Quartile4 v Quartile1 = 1.64, 95{\%} confidence interval: 1.15-2.32, P = .01) after adjustment for other biomarkers and standard stroke risk factors. The BRS identified a gradient of increasing stroke risk with a greater number of elevated inflammatory/hemostasis biomarkers, and improved the c index significantly compared with standard stroke risk factors (P = .02). Among the subset of individuals who met current criteria for high-risk levels of CRP (>3.0 mg/L), the BRS defined an approximately 2-fold gradient of risk. We found no evidence for a relationship between stroke and levels of E-selectin, fibrinogen, tumor necrosis factor-α, vascular cell adhesion molecule-1, prothrombin fragment 1+2, Factor VIIC, or plasminogen activator inhibitor-1 antigen (P > .15). Discussion: The findings support the further exploration of multiple biomarker panels to develop approaches for stratifying an individual's risk of stroke.",
author = "Kaplan, {Robert C.} and McGinn, {Aileen P.} and Baird, {Alison E.} and Hendrix, {Susan L.} and Charles Kooperberg and John Lynch and Rosenbaum, {Daniel M.} and Karen Johnson and Strickler, {Howard D.} and Sylvia Wassertheil-Smoller",
year = "2008",
month = "11",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2008.04.006",
language = "English (US)",
volume = "17",
pages = "344--355",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women

T2 - The Women's Health Initiative Observational Study

AU - Kaplan, Robert C.

AU - McGinn, Aileen P.

AU - Baird, Alison E.

AU - Hendrix, Susan L.

AU - Kooperberg, Charles

AU - Lynch, John

AU - Rosenbaum, Daniel M.

AU - Johnson, Karen

AU - Strickler, Howard D.

AU - Wassertheil-Smoller, Sylvia

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background: Inflammatory and hemostasis-related biomarkers may identify women at risk of stroke. Methods: Hormones and Biomarkers Predicting Stroke is a study of ischemic stroke among postmenopausal women participating in the Women's Health Initiative observational study (n = 972 case-control pairs). A Biomarker Risk Score (BRS) was derived from levels of 7 inflammatory and hemostasis-related biomarkers that appeared individually to predict risk of ischemic stroke: C-reactive protein (CRP), interleukin-6, tissue plasminogen activator, D-dimer, white blood cell count, neopterin, and homocysteine. The c index was used to evaluate discrimination. Results: Of all the individual biomarkers examined, CRP emerged as the only independent single predictor of ischemic stroke (adjusted odds ratio comparing Quartile4 v Quartile1 = 1.64, 95% confidence interval: 1.15-2.32, P = .01) after adjustment for other biomarkers and standard stroke risk factors. The BRS identified a gradient of increasing stroke risk with a greater number of elevated inflammatory/hemostasis biomarkers, and improved the c index significantly compared with standard stroke risk factors (P = .02). Among the subset of individuals who met current criteria for high-risk levels of CRP (>3.0 mg/L), the BRS defined an approximately 2-fold gradient of risk. We found no evidence for a relationship between stroke and levels of E-selectin, fibrinogen, tumor necrosis factor-α, vascular cell adhesion molecule-1, prothrombin fragment 1+2, Factor VIIC, or plasminogen activator inhibitor-1 antigen (P > .15). Discussion: The findings support the further exploration of multiple biomarker panels to develop approaches for stratifying an individual's risk of stroke.

AB - Background: Inflammatory and hemostasis-related biomarkers may identify women at risk of stroke. Methods: Hormones and Biomarkers Predicting Stroke is a study of ischemic stroke among postmenopausal women participating in the Women's Health Initiative observational study (n = 972 case-control pairs). A Biomarker Risk Score (BRS) was derived from levels of 7 inflammatory and hemostasis-related biomarkers that appeared individually to predict risk of ischemic stroke: C-reactive protein (CRP), interleukin-6, tissue plasminogen activator, D-dimer, white blood cell count, neopterin, and homocysteine. The c index was used to evaluate discrimination. Results: Of all the individual biomarkers examined, CRP emerged as the only independent single predictor of ischemic stroke (adjusted odds ratio comparing Quartile4 v Quartile1 = 1.64, 95% confidence interval: 1.15-2.32, P = .01) after adjustment for other biomarkers and standard stroke risk factors. The BRS identified a gradient of increasing stroke risk with a greater number of elevated inflammatory/hemostasis biomarkers, and improved the c index significantly compared with standard stroke risk factors (P = .02). Among the subset of individuals who met current criteria for high-risk levels of CRP (>3.0 mg/L), the BRS defined an approximately 2-fold gradient of risk. We found no evidence for a relationship between stroke and levels of E-selectin, fibrinogen, tumor necrosis factor-α, vascular cell adhesion molecule-1, prothrombin fragment 1+2, Factor VIIC, or plasminogen activator inhibitor-1 antigen (P > .15). Discussion: The findings support the further exploration of multiple biomarker panels to develop approaches for stratifying an individual's risk of stroke.

UR - http://www.scopus.com/inward/record.url?scp=54849433571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54849433571&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2008.04.006

DO - 10.1016/j.jstrokecerebrovasdis.2008.04.006

M3 - Article

C2 - 18984425

AN - SCOPUS:54849433571

VL - 17

SP - 344

EP - 355

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 6

ER -